Dealing In Aspen Securities ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) ("Aspen Holdings") Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 ("Aspen" or "the Company") DEALING IN ASPEN SECURITIES In compliance with the JSE Limited Listings Requirements, shareholders are advised of the following dealings in Aspen's securities by a third-party intermediary ("the Intermediary"). A hedging transaction was entered into with the Intermediary to enable the Company to settle its future obligation to employees participating in the SA Management Deferred Incentive Bonus Scheme ("the Scheme") of Aspen and three of its wholly owned South African subsidiaries, namely Pharmacare Limited, Aspen Finance (Pty) Limited and Fine Chemicals Corporation (Pty) Ltd. In terms of this hedging transaction the Intermediary acquired Aspen shares as follows: Date of transaction: 26 November 2024 Nature and details of transaction On-market purchase of securities to satisfy the future by intermediary: obligations towards participants of the Scheme Number of securities: 367 662 Purchase price: R169.00 Total value of the transaction: R62 134 878 Class of securities: Ordinary Shares Nature of interest: Direct beneficial Clearance obtained: Yes Durban 28 November 2024 Sponsor: Investec Bank Limited Date: 28-11-2024 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.